Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
Christoph StraubeHagen ScherbJens GemptJan KirschkeClaus ZimmerFriederike Schmidt-GrafBernhard MeyerStephanie E CombsPublished in: BMC cancer (2018)
The trial was prospectively registered at clinicaltrials.gov ( NCT02715297 , registration date February 29th, 2016). The protocol presented hereby refers to the version 1.2 of the protocol (January 11th, 2017).